| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.14 | 3e-05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 8e-05 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0002 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.17 | 0.0007 |
| mRNA | Topotecan | FIMM | pan-cancer | AAC | -0.33 | 0.0007 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.15 | 0.0008 |